Migraine and reproductive life

Handbook of Clinical Neurology

Volumn 97, Issue C, 2010, Pages 303-322

  Nappi, Rossella E ^a   Berga, Sarah L ^b  

^a UNIVERSITY OF PAVIA   (Italy)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN; MENARCHE; MENOPAUSE; MENSTRUAL CYCLE; MENSTRUATION; MIGRAINE;

HUMANS; MENARCHE; MENOPAUSE; MENSTRUAL CYCLE; MENSTRUATION; MIGRAINE DISORDERS;

EID: 77956283220     PISSN: 00729752     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0072-9752(10)97025-5     Document Type: Book

References (158)

1. Adams Hillard P.J. Menstruation in young girls: a clinical perspective. Obstet Gynecol 2002, 99:655-662.
2. Aegidius K., Zwart J.A., Hagen K., et al. Oral contraceptives and increased headache prevalence: the Head-HUNT Study. Neurology 2006, 66:349-353.
3. Aegidius K.L., Zwart J.A., Hagen K., et al. Hormone replacement therapy and headache prevalence in postmenopausal women. The Head-HUNT study. Eur J Neurol 2007, 14:73-78.
4. Amir B.Y., Yaacov B., Guy B., et al. Headaches in women undergoing in vitro fertilization and embryo-transfer treatment. Headache 2005, 45:215-219.
5. Avis N.E., McKinlay S.M. A longitudinal analysis of women's attitudes toward the menopause: results from the Massachusetts Women's Health Study. Maturitas 1991, 13:65-79.
6. Beckham J.C., Krug L.M., Penzien D.B., et al. The relationship of ovarian steroids, headache activity and menstrual distress: a pilot study with female migraineurs. Headache 1992, 32:292-297.
7. Benagiano G., Bastianelli C., Farris M. Contraception today. Ann N Y Acad Sci 2006, 1092:1-32.
8. Bono G., Neri I., Granella F., et al. Factors associated with pain complaints in a clinical sample of postmenopausal women. J Psychosom Obstet Gynecol 1995, 16:117-121.
9. Bousser M.G., Conard J., Kittner S., et al. Recommendations on the risk of ischaemic stroke associated with use of combined oral contraceptives and hormone replacement therapy in women with migraine. The International Headache Society Task Force on Combined Oral Contraceptives and Hormone Replacement Therapy. Cephalalgia 2000, 20:155-156.
10. Brandes J.L. The influence of estrogen on migraine: a systematic review. JAMA 2006, 295:1824-1830.
11. Buhimschi C.S. Endocrinology of lactation. Obstet Gynecol Clin North Am 2004, 31:963-979. xii.
12. Burger H.G., Hale G.E., Robertson D.M., et al. A review of hormonal changes during the menopausal transition: focus on findings from the Melbourne Women's Midlife Health Project. Hum Reprod Update 2007, 13:559-565.
13. Cachrimanidou A.C., Hellberg D., Nilsson S., et al. Long-interval treatment regimen with a desogestrel-containing oral contraceptive. Contraception 1993, 48:205-216.
14. Callaghan N. The migraine syndrome in pregnancy. Neurology 1968, 18:197-201.
15. Campbell O.M., Gray R.H. Characteristics and determinants of postpartum ovarian function in women in the United States. Am J Obstet Gynecol 1993, 169:55-60.
16. Chancellor A.M., Wroe S.J., Cull R.E. Migraine occurring for the first time in pregnancy. Headache 1990, 30:224-227.
17. Chen T.-C., Leviton A. Headache recurrence in pregnant women with migraine. Headache 1994, 34:107-110.
18. Chumlea W.C., Schubert C.M., Roche A.F., et al. Age at menarche and racial comparisons in US girls. Pediatrics 2003, 111:110-113.
19. Coffee A.L., Sulak P.J., Kuehl T.J. Long-term assessment of symptomatology and satisfaction of an extended oral contraceptive regimen. Contraception 2007, 75:444-449.
20. Cogan R., Spinnato J.A. Pain and discomfort thresholds in late pregnancy. Pain 1980, 27:63-68.
21. Couturier E.G., Bomhof M.A., Neven A.K., et al. Menstrual migraine in a representative Dutch population sample: prevalence, disability and treatment. Cephalalgia 2003, 23:302-308.
22. Cupini L.M., Matteis M., Troisi E., et al. Sex-hormone-related events in migrainous females. A clinical comparative study between migraine with aura and migraine without aura. Cephalalgia 1995, 15:140-144.
23. Curtis K.M., Chrisman C.E., Peterson H.B. Contraception for women in selected circumstances. Obstet Gynecol 2002, 99:1100-1102.
24. Dalton K. Migraine and oral contraceptives. Headache 1976, 15:247-251.
25. Dawson-Basoa M.B., Gintzler A.R. 17-Beta-estradiol and progesterone modulate an intrinsic opioid analgesic system. Brain Res 1993, 601:241-245.
26. de Lignieres B., MacGregor E.A. Risks and benefits of hormone replacement therapy. Cephalalgia 2000, 20:164-169.
27. de Lignieres B., Vincens M., Mauvais-Jarvis P., et al. Prevention of menstrual migraine by percutaneous oestradiol. BMJ 1986, 293:1540.
28. Dennerstein L., Morse C., Burrows G., et al. Menstrual migraine: a double-blind trial of percutaneous estradiol. Gynecol Endocrinol 1988, 2:113-120.
29. Dzoljic E., Sipetic S., Vlajinac H., et al. Prevalence of menstrually related migraine and nonmigraine primary headache in female students of Belgrade University. Headache 2002, 42:185-193.
30. Epstein M.T., Hockaday J.M., Hockaday T.D.R. Migraine and reproductive hormones throughout the menstrual cycle. Lancet 1975, 1:543-547.
31. Facchinetti F. The premenstrual syndrome belongs in the diagnostic criteria for menstrual migraine. Cephalalgia 1994, 14:413-414.
32. Facchinetti F., Sances G., Borella P., et al. Magnesium prophylaxis of menstrual migraine: effects on intracellular magnesium. Headache 1991, 31:298-301.
33. Facchinetti F., Neri I., Martignoni E., et al. The association of menstrual migraine with the premenstrual syndrome. Cephalalgia 1993, 13:422-425.
34. Facchinetti F., Nappi R.E., Tirelli A., et al. Hormone supplementation differently affects migraine in postmenopausal women. Headache 2002, 42:924-929.
35. Facchinetti F., Allais G., D'Amico R., et al. The relationship between headache and preeclampsia: a case-control study. Eur J Obstet Gynecol Reprod Biol 2005, 121:143-148.
36. Ferrero S., Pretta S., Bertoldi S., et al. Increased frequency of migraine among women with endometriosis. Hum Reprod 2004, 19:2927-2932.
37. Fettes I. (1999). Migraine in the menopause. Neurology 1999, 53:S29-S33.
38. Fioroni L., Martignoni E., Facchinetti F. Changes of neuroendocrine axes in patients with menstrual migraine. Cephalalgia 1995, 15:297-300.
39. Genazzani A.R., Bernardi F. The brain as a new frontier for reproductive endocrinology. Curr Opin Obstet Gynecol 1999, 11:237-240.
40. Genazzani A.R., Facchinetti F., Parrini D. β-Lipotrophin and β-endorphin plasma levels during pregnancy. Clin Endocrinol 1980, 14:409-418.
41. Genazzani A.R., Petraglia F., Gamba O., et al. Neuroendocrinology of the menstrual cycle. Ann N Y Acad Sci 1997, 816:143-150.
42. Genazzani A.R., Stomati M., Morittu A., et al. Progesterone, progestagens and the central nervous system. Hum Reprod 2000, 15:S14-S27.
43. Granella F., Sances G., Zanferrari C., et al. Migraine without aura and reproductive life events: a clinical epidemiological study in 1300 women. Headache 1993, 33:385-389.
44. Granella F., Sances G., Pucci E., et al. Migraine with aura and reproductive life events: a case control study. Cephalalgia 2000, 20:701-707.
45. Granella F., Sances G., Allais G., et al. Characteristics of menstrual and non-menstrual attacks in women with menstrually-related migraine. Cephalagia 2004, 24:707-716.
46. Greendale G.A., Reboussin B.A., Hogan P., et al. Symptom relief and side effects of postmenopausal hormones: results from the Postmenopausal Estrogen/Progestin Interventions Trial. Obstet Gynecol 1998, 92:982-988.
47. Grumbach M.M. The neuroendocrinology of human puberty revisited. Horm Res 2002, 57:S2-S14.
48. Hampton N.R., Rees M.C., Lowe D.G., et al. Levonorgestrel intrauterine system (LNG-IUS) with conjugated oral equine estrogen: a successful regimen for HRT in perimenopausal women. Hum Reprod 2005, 20:2653-2660.
49. Headache Classification Subcommittee of the International Headache Society The international classification of headache disorders. Cephalalgia 2004, 24:1-160. 2nd edn.
50. Hodson J., Thompson J., Al-Azzawi F. (2000). Headache at menopause and in hormone replacement therapy users. Climacteric 2000, 3:119-124.
51. Jabbour H.N., Kelly R.W., Fraser H.M., et al. Endocrine regulation of menstruation. Endocr Rev 2006, 27:17-46.
52. Jamieson D.J., Steege J.F. The prevalence of dysmenorrhea, dyspareunia, pelvic pain, and irritable bowel syndrome in primary care practices. Obstet Gynecol 1996, 87:55-58.
53. Johannes C.B., Linet M.S., Stewart W.F., et al. Relationship of headache to phase of the menstrual cycle among young women: a daily diary study. Neurology 1995, 45:1076-1082.
54. Johnson S.R. Premenstrual syndrome, premenstrual dysphoric disorder, and beyond: a clinical primer for practitioners. Obstet Gynecol 2004, 104:845-859.
55. Karwautz A., Wöber-Bingöl C., Wöber C. Freud and migraine: the beginning of a psychodynamically oriented view of headache a hundred years ago. Cephalalgia 1996, 16:22-26.
56. Kaufman J.M. Pharmacokinetics of estrogens and hormone replacement therapy. Eur Menopause J 1997, 4:14-22.
57. Kornstein S.G., Parker A.J. Menstrual migraines: etiology, treatment, and relationship to premenstrual syndrome. Curr Opin Obstet Gynecol 1997, 9:154-159.
58. Kudrow L. The relationship of headache frequency to hormone use in migraine. Headache 1975, 15:36-40.
59. LaGuardia K.D., Fisher A.C., Bainbridge J.D., et al. Suppression of estrogen-withdrawal headache with extended transdermal contraception. Fertil Steril 2005, 83:1875-1877.
60. Lance J.W., Anthony M. Some clinical aspects of migraine. A prospective survey of 500 patients. Arch Neurol 1966, 15:356-361.
61. Lee L.K. Physiological adaptations of pregnancy affecting the nervous system. Semin Neurol 2007, 27:405-410.
62. Li W., Zheng T., Altura B.M., et al. Sex steroid hormones exert biphasic effects on cytosolic magnesium ions in cerebral vascular smooth muscle cells: possible relationships to migraine frequency in premenstrual syndromes and stroke incidence. Brain Res Bull 2001, 54:83-89.
63. Lichten E.M., Lichten J.B., Whitty A., et al. The confirmation of a biochemical marker for women's hormonal migraine: the depo-estradiol challenge test. Headache 1996, 36:367-371.
64. Lipton R.B., Bigal M.E. Migraine: epidemiology, impact, and risk factors for progression. Headache 2005, 45(Suppl. 1):S3-S13.
65. Lipton R.B., Stewart W.F. Migraine in the United States: a review of epidemiology and health care use. Neurology 1993, 43:S6-S10.
66. Lipton R.B., Bigal M.E., Diamond M., et al. Migraine prevalence, disease burden, and the need for preventive therapy. Neurology 2007, 68:343-349.
67. Loder E. Migraine in pregnancy. Semin Neurol 2007, 27:425-433.
68. Loder E.W., Buse D.C., Golub J.R. Headache and combination estrogen-progestin oral contraceptives: integrating evidence, guidelines, and clinical practice. Headache 2005, 45:224-231.
69. Loder E., Rizzoli P., Golub J. Hormonal management of migraine associated with menses and the menopause: a clinical review. Headache 2007, 47:329-340.
70. Lyngberg A.C., Rasmussen B.K., Jorgensen T., et al. Has the prevalence of migraine and tension-type headache changed over a 12-year period? A Danish population survey. Eur J Epidemiol 2005, 20:243-249.
71. MacGregor A. Gynecological aspects of migraine. Rev Contemp Pharmacother 2000, 11:75-90.
72. MacGregor E.A. " Menstrual" migraine: towards a definition. Cephalalgia 1996, 16:11-21.
73. MacGregor E.A. Menstruation, sex hormones, and migraine. Neurol Clin 1997, 15:125-141.
74. MacGregor E.A. Estrogen replacement and migraine aura. Headache 1999, 39:674-678.
75. MacGregor E.A. Effect of oral and transdermal estrogen replacement on migraine. Cephalalgia 1999, 19:124-125.
76. MacGregor E.A. Hormonal contraception and migraine. J Fam Plann Reprod Health Care 2001, 27:49-52.
77. MacGregor E.A. Oestrogen and attacks of migraine with and without aura. Lancet Neurol 2004, 3:354-361.
78. MacGregor E.A. Female sex hormones and migraine. Rev Neurol (Paris) 2005, 161:677-678.
79. MacGregor E.A. Migraine and the menopause. J Br Menopause Soc 2006, 12:104-108.
80. MacGregor E.A., Barnes D. Migraine in a specialist menopause clinic. Climacteric 1999, 2:218-223.
81. MacGregor E.A., Hackshaw A. Prevalence of migraine on each day of the natural menstrual cycle. Neurology 2004, 63:351-353.
82. MacGregor E.A., Chia H., Vohrah R.C., et al. Migraine and menstruation: a pilot study. Cephalalgia 1990, 10:305-310.
83. MacGregor E.A., Frith A., Ellis J., et al. Incidence of migraine relative to menstrual cycle phases of rising and falling estrogen. Neurology 2006, 67:2154-2158.
84. MacGregor E.A., Frith A., Ellis J., et al. Prevention of menstrual attacks of migraine: a double-blind placebo-controlled crossover study. Neurology 2006, 67:2159-2163.
85. Maggioni F., Alessi C., Maggino T., et al. Headache during pregnancy. Cephalalgia 1997, 17:765-769.
86. Marcoux S., Berube S., Brisson J., et al. History of migraine and risk of pregnancy-induced hypertension. Epidemiology 1992, 3:53-56.
87. Marcus D.A. Headache in pregnancy. Curr Pain Headache Rep 2003, 7:288-296.
88. Marcus D.A., Scharff L., Turk D. Longitudinal prospective study of headache during pregnancy and postpartum. Headache 1999, 39:625-632.
89. Martin V.T., Behbehani M. Ovarian hormones and migraine headache: understanding mechanisms and pathogenesis - part I. Headache 2006, 46:3-23.
90. Martin V.T., Behbehani M. Ovarian hormones and migraine headache: understanding mechanisms and pathogenesis - part 2. Headache 2006, 46:365-386.
91. Martin V., Wernke S., Mandell K., et al. Medical oophorectomy with and without estrogen add-back therapy in the prevention of migraine headache. Headache 2003, 43:309-321.
92. Martin V., Wernke S., Mandell K., et al. Defining the relationship between ovarian hormones and migraine headache. Headache 2005, 45:1190-1201.
93. Martin V.T., Wernke S., Mandell K., et al. Symptoms of premenstrual syndrome and their association with migraine headache. Headache 2006, 46:125-137.
94. Massiou H., MacGregor E.A. Evolution and treatment of migraine with oral contraceptives. Cephalalgia 2000, 20:170-174.
95. Mattsson P. Hormonal factors in migraine: A population-based study of women aged 40 to 74 years. Headache 2003, 43:27-35.
96. Miller L., Notter K.M. Menstrual reduction with extended use of combination oral contraceptive pills: randomized controlled trial. Obstet Gynecol 2001, 98:771-778.
97. Misakian A.L., Langer R.D., Bensenor I.M., et al. Postmenopausal hormone therapy and migraine headache. J Womens Health 2003, 12:1027-1036.
98. Modena M.G., Sismondi P., Mueck A.O., et al. New evidence regarding hormone replacement therapies is urgently required transdermal postmenopausal hormone therapy differs from oral hormone therapy in risks and benefits. Maturitas 2005, 52:1-10.
99. Moore M.P., Redman C.W.G. Case-control study of severe pre-eclampsia of early onset. BMJ 1983, 287:580-583.
100. Mortimer M.J., Kay J., Jaron A. Childhood migraine in general practice: clinical features and characteristics. Cephalalgia 1992, 12:238-243.
101. Mortimer M.J., Kay J., Jaron A. Epidemiology of headache and childhood migraine in an urban general practice using Ad Hoc, Vahlquist and IHS criteria. Dev Med Child Neurol 1992, 34:1095-1101.
102. Mueller L. Predictability of exogenous hormone effect on subgroups of migraineurs. Headache 2000, 40:189-193.
103. Murray S.C., Muse K.N. Effective treatment of severe menstrual migraine headaches with gonadotropin-releasing hormone agonist and " add-back" therapy. Fertil Steril 1997, 67:390-393.
104. Nand S.L., Webster M.A., Baber R., et al. Menopausal symptom control and side-effects on continuous estrone sulfate and three doses of medroxyprogesterone acetate. Ogen/Provera Study Group. Climacteric 1998, 1:211-218.
105. Nappi G., Facchinetti F., Rossi F. Headache and menstrually related disorders: in search of a consensus. Cephalalgia 1997, 17(Suppl. 20).
106. Nappi G., Jensen R., Nappi R.E., et al. Diaries and calendars for migraine. A review. Cephalalgia 2006, 26:905-916.
107. Nappi R.E., Veneroni F., Chiapparini I., et al. Gonadal hormones and migraine: a tight bondage within the female brain. Semin Headache Manage 1999, 4:11-15.
108. Nappi R.E., Cagnacci A., Granella F., et al. Course of primary headaches during hormone replacement therapy. Maturitas 2001, 38:157-163.
109. Nappi R.E., Sances G., Brundu B., et al. Neuroendocrine response to the serotonin agonist m-chlorophenylpiperazine in women with menstrual status migrainosus. Neuroendocrinology 2003, 78:52-60.
110. Nappi R.E., Sances G., Brundu B., et al. Estradiol supplementation modulates neuroendocrine response to M-chlorophenylpiperazine in menstrual status migrainosus triggered by oral contraception-free interval. Hum Reprod 2005, 20:3423-3428.
111. Nappi R.E., Sances G., Sommacal A., et al. Different effects of tibolone and low-dose EPT in the management of postmenopausal women with primary headaches. Menopause 2006, 13:818-825.
112. Nattero G., Allais G., De Lorenzo C., et al. Relevance of prostaglandins in true menstrual migraine. Headache 1989, 29:233-238.
113. Neri I., Granella F., Nappi R., et al. Characteristics of headache at menopause: a clinico-epidemiologic study. Maturitas 1993, 17:31-37.
114. Oldenhave A., Jaszmann L.J., Everaerd W.T., et al. Hysterectomized women with ovarian conservation report more severe climacteric complaints than do normal climacteric women of similar age. Am J Obstet Gynecol 1993, 168:765-771.
115. Pardutz A., Multon S., Malgrange B., et al. Effect of systemic nitroglycerin on CGRP and 5-HT afferents to rat caudal spinal trigeminal nucleus and its modulation by estrogen. Eur J Neurosi 2002, 15:1803-1809.
116. Petraglia F., Florio P., Nappi C., et al. Peptide signaling in human placenta and membranes: autocrine, paracrine, and endocrine mechanisms. Endocr Rev 1996, 17:156-186.
117. Pradalier A., Vincent D., Beaulieu P., et al. Correlation between oestradiol plasma level and therapeutic effect on menstrual migraine. New Advances in Headache Research 1994, Vol. 4:129-132. Smith-Gordon, London. C. Rose (Ed.).
118. Rasmussen B.K. Migraine and tension-type headache in a general population: precipitating factors, female hormones, sleep pattern and relation to lifestyle. Pain 1993, 53:65-72.
119. Rasmussen B.K. Epidemiology of headache. Cephalalgia 1995, 15:45-68.
120. Ryan R.E. A controlled study of the effect of oral contraceptives on migraine. Headache 1978, 17:250-251.
121. Sances G., Granella F., Nappi R.E., et al. Course of migraine during pregnancy and postpartum: a prospective study. Cephalalgia 2003, 23:197-205.
122. Scharff L., Marcus D.A., Turk D.C. Headache during pregnancy and in the postpartum: a prospective study. Headache 1997, 37:203-210.
123. Scher A.I., Terwindt G.M., Picavet H.S.J., et al. Cardiovascular risk factors and migraine: the GEM population-based study. Neurology 2005, 64:614-620.
124. Silberstein S.D. The role of sex hormones in headache. Neurology 1992, 42:37-42.
125. Silberstein S.D. Migraine and pregnancy. Neurol Clin 1997, 15:209-231.
126. Silberstein S.D., Lipton R.B., Goadsby P.J. Headache in clinical practice 1998, Oxford, Isis Medical Media, 61-90.
127. Silberstein S.D. Sex hormones and headache. Rev Neurol (Paris) 2000, 156(Suppl. 4):4S30. 4S41.
128. Silberstein S.D., Merriam G.R. Estrogens, progestins and headache. Neurology 1991, 41:786-793.
129. Small R., Friedman G.D., Ettinger B. Concomitant medication use in postmenopausal women using estrogen therapy. Menopause 2001, 8:120-126.
130. Solomon G.D., Kunkel R.S., Frame J. Demographics of headache in elderly patients. Headache 1990, 30:273-276.
131. Somerville B.W. Plasma estradiol level linked to migraine during menstrual period. JAMA 1972, 221:845-846.
132. Somerville B.W. The role of estradiol withdrawal in the etiology of menstrual migraine. Neurology 1972, 22:355-365.
133. Somerville B.W. A study of migraine in pregnancy. Neurology 1972, 22:824-828.
134. Somerville B.W. Estrogen-withdrawal migraine. Neurology 1975, 25:239-244.
135. Somerville B.W. Estrogen-withdrawal migraine. I. Duration of exposure required and attempted prophylaxis by premenstrual estrogen administration. Neurology 1975, 25:239-244.
136. Somerville B.W. Estrogen-withdrawal migraine. II. Attempted prophylaxis by continuous estradiol administration. Neurology 1975, 25:245-250.
137. Speroff L., Glass R.H., Kase N.G. Clinical Gynecologic Endocrinology and Infertility 1994, Williams and Wilkins, Baltimore. 5th edn.
138. Stein G.S. Headaches in the first post partum week and their relationship to migraine. Headache 1981, 21:201-205.
139. Stewart W.F., Linet M.S., Celentano D.D., et al. Age- and sex-specific incidence rates of migraine with and without visual aura. Am J Epidemiol 1991, 134:1111-1120.
140. Stewart W.F., Lipton R.B., Celentano D.D., et al. Prevalence of migraine headache in the United States. Relation to age, income, race, and other sociodemographic factors. JAMA 1992, 267:64-69.
141. Stewart W.F., Lipton R.B., Chee E., et al. Menstrual cycle and headache in a population sample of migraineurs. Neurology 2000, 55:1517-1523.
142. Stovner L.J., Zwart J.A., Hagen K., et al. Epidemiology of headache in Europe. Eur J Neurol 2006, 13:333-345.
143. Sulak P.J., Scow R.D., Preece C., et al. Hormone withdrawal symptoms in oral contraceptive users. Obstet Gynecol 2000, 95:261-266.
144. Sulak P.J., Kuehl T.J., Ortiz M., et al. Acceptance of altering the standard 21-day/7-day oral contraceptive regimen to delay menses and reduce hormone withdrawal symptoms. Am J Obstet Gynecol 2002, 186:1142-1149.
145. Sulak P., Willis S., Kuehl T., et al. Headaches and oral contraceptives: impact of eliminating the standard 7-day placebo interval. Headache 2007, 47:27-37.
146. Tarin J.J., Brines J., Cano A. Long-term effects of delayed parenthood. Hum Reprod 1998, 13:2371-2376.
147. Tena-Sempere M. Kiss-1 and reproduction: focus on its role in the metabolic regulation of fertility. Neuroendocrinology 2006, 83:275-281.
148. Terasawa E., Fernandez D.L. Neurobiological mechanisms of the onset of puberty in primates. Endocr Rev 2001, 22:111-151.
149. Tervila L., Marttila P. Headache as a symptom of endometriosis externa. Ann Chir Gynaecol Fenn 1975, 64:239-241.
150. Tietjen G.E., Bushnell C.D., Herial N.A., et al. Endometriosis is associated with prevalence of comorbid conditions in migraine. Headache 2007, 47:1069-1078.
151. US Department of Health and Human Services Public Health Service Fast Facts About Endometriosis 2006, National Institute of Child Health and Human Development, New York.
152. Wang S.J., Fuh J.L., Lu S.R., et al. Migraine prevalence during menopausal transition. Headache 2003, 43:470-478.
153. Welch K.M., Darnley D., Simkins R.T. The role of estrogen in migraine: a review and hypothesis. Cephalalgia 1984, 4:227-236.
154. Welch K.M., Brandes J.L., Berman N.E. Mismatch in how oestrogen modulates molecular and neuronal function may explain menstrual migraine. Neurol Sci 2006, 27:S190-S192.
155. Whitty C.W., Hockaday J.M., Whitty M.M. The effect of oral contraceptives on migraine. Lancet 1966, 1:856-859.
156. Wright G.D., Patel M.K. Focal migraine and pregnancy. BMJ 1986, 293:1557-1558.
157. Yen, Jaffe Reproductive Endocrinology 2004, Elsevier Saunders, Philadelphia. 5th edn.
158. Zondervan K.T., Yudkin P.L., Vessey M.P., et al. Prevalence and incidence in primary care of chronic pelvic pain in women: evidence from a national general practice database. Br J Obstet Gynaecol 1999, 106:1149-1155.